These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 921258)
1. In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria. Shadomy S; Wagner G; Carver M Antimicrob Agents Chemother; 1977 Nov; 12(5):609-13. PubMed ID: 921258 [TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil. Luh KT; Chao HP; Ho SW; Hsieh WC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of five oral cephalosporins against anaerobic pathogenic bacteria. Shadomy S; Mayhall CG; Apollo E J Infect Dis; 1977 Nov; 136(5):697-700. PubMed ID: 915342 [TBL] [Abstract][Full Text] [Related]
4. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics. Jones RN; Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560 [No Abstract] [Full Text] [Related]
5. Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine. Silver MS; Counts GW; Zeleznik D; Turck M Antimicrob Agents Chemother; 1977 Nov; 12(5):591-6. PubMed ID: 921255 [TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor. Bill NJ; Washington JA Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005 [TBL] [Abstract][Full Text] [Related]
7. Cefatrizine activity compared with that of other cephalosporins. Neu HC; Fu KP Antimicrob Agents Chemother; 1979 Feb; 15(2):209-12. PubMed ID: 426514 [TBL] [Abstract][Full Text] [Related]
8. The in vitro spectrum of the cephalosporins. Washington JA Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595 [TBL] [Abstract][Full Text] [Related]
9. Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin. Actor P; Uri JV; Phillips L; Sachs CS; Guarini JR; Zajac I; Berges DA; Dunn GL; Hoover JR; Weisbach JA J Antibiot (Tokyo); 1975 Aug; 28(8):594-601. PubMed ID: 808525 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Kamimura T; Kojo H; Matsumoto Y; Mine Y; Goto S; Kuwahara S Antimicrob Agents Chemother; 1984 Jan; 25(1):98-104. PubMed ID: 6561017 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of clinical isolates of gram-positive and gram-negative organisms to cefatrizine. Carlone NA; Cuffini AM; Forno Pizzoglio M; Cavallo G Drugs Exp Clin Res; 1985; 11(7):447-51. PubMed ID: 3836867 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of five oral cephalosporins in calves. Soback S; Ziv G; Kurtz B; Paz R Res Vet Sci; 1987 Sep; 43(2):166-72. PubMed ID: 3317582 [TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins. Blackwell CC; Freimer EH; Tuke GC Antimicrob Agents Chemother; 1976 Aug; 10(2):288-92. PubMed ID: 984771 [TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model. Leitner F; Goodhines RA; Buck RE; Price KE J Antibiot (Tokyo); 1979 Jul; 32(7):718-26. PubMed ID: 541265 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of selected bacteria to cefaclor. Valenti AJ; Andriole VT Yale J Biol Med; 1977; 50(5):465-9. PubMed ID: 341537 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin. Simon C Infection; 1987; 15(2):122-4. PubMed ID: 3596808 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins. Vuye A; Pijck J; Soep H Antimicrob Agents Chemother; 1976 Mar; 9(3):422-32. PubMed ID: 1259401 [TBL] [Abstract][Full Text] [Related]
19. Drug susceptibility-resistance pattern of gram-negative uropathogens to seven cephalosporins. Seneca H Am J Med Sci; 1973 Nov; 266(5):381-5. PubMed ID: 4202701 [No Abstract] [Full Text] [Related]
20. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin. Tomatsu K; Ando S; Masuyoshi S; Kondo S; Hirano M; Miyaki T; Kawaguchi H J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]